Neurotype Inc.
Objective craving biomarkers and neurofeedback for relapse prevention
NeuromarkR™ measures environmentally triggers for addiction with EEG, and Modit™ is designed to deliver targeted neurofeedback for craving modulation.
How It Works
Our platform (EEG + analytics + protocols) provides a comprehensive approach to measuring and managing environmentally triggered / cue-induced craving.
Assess with NeuromarkR™
NeuromarkR™ is an EEG-based assessment platform designed to characterize cue-elicited neural responses in research and clinical study settings.
Review the NeuromarkR™ Report
NeuromarkR™ generates Clinical Decision Support reports that characterize craving biomarkers, providing potentially valuable information for downstream care planning.
Train with Modit™
Modit™ is a closed-loop neurofeedback training system designed to modulate cue-elicited neural activity.
NeuromarkR™ EEG-Based Assessment Platform
Objectively manage triggers for cravings in recovery.
Treatment Companion
Breakthrough device to track progress in Substance Use Disorder recovery
Measurement Based Care
Complements psychological, pharmacological, and neuromodulation therapies where neuroplasticity is critical
Quantitative Insights
Quantitative insights into measuring craving objectively with innovative neurotechnology
Evidence-Based
More than 30 years of peer-reviewed published neuroscience research on craving and addiction
Overcoming Triggers
More than 50% of people treated for Substance Use Disorder relapse within months often due to unmanaged triggers and cravings.
Substance Use Triggers are Everywhere
Triggers like visiting familiar places, seeing substance use in media, or meeting old friends can subconsciously lead to substance seeking, with potentially life-threatening consequences.
Deeply Rooted in the Brain’s Reward System
Drug use activates the brain’s reward system, reinforcing behavior. Over time, this system becomes hyper-sensitive to drug-related cues, causing cravings and relapse, even years after stopping.
The Need for Better Treatment
Conventional treatments offer partial relief but fail to address the brain’s trigger responses. Effective treatment requires personalized interventions to reshape the brain’s reward system.
Innovating Medical Solutions for Triggers
Neurotype Inc.'s NeuromarkR™ device monitors brain biomarkers to quantify triggers' impacts. Our investigational platform is being studied to enable targeted therapy, with the hypothesis that it may support brain function normalization and relapse prevention.
How to Engage with Neurotype
We welcome inquiries from researchers, clinicians, partners, and those interested in supporting our mission.
Clinical Pilot / Lab Collaboration
Contact us for collaboration inquiries on research studies and clinical pilot programs.
Academic Research Use
Explore opportunities to use our platform in academic research settings.
Advising / Partnership
Join us as an advisor or partner in advancing addiction neuroscience.
Investment Interest
Learn about investment opportunities in breakthrough neurotechnology.
Clinical Purchase Inquiry
Inquire about purchasing our platform for clinical use in your practice.
Patient / Family Interest
Not available yet for direct use, but you can tell your care provider about Neurotype.
Want to Learn More?
Want to learn more about how Neurotype Inc. is advancing addiction treatment research?
